Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: C501- Malignant neoplasm of central portion of breast Health Condition 3: C500- Malignant neoplasm of nipple and areola Health Condition 4: C508- Malignant neoplasm of overlappingsites of breast
Conditions
Interventions
Intervention1: Vitamin D and Calcium: With Blinding, Study Group Will Be Supplemented With 50000 IU Vitamin D Once Weekly For One Month And Tab Calcium 500 Mg BD Daily For The Entire Chemotherapy D
Sponsors
King George Medical University UP
Eligibility
Inclusion criteria
Inclusion criteria: 1. Naïve Stage II/III breast cancer patients consenting for NACT.
Exclusion criteria
Exclusion criteria: 1. Patients with osteoporosis and parathyroid disorders. 2. Patients not consenting for chemotherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effect of vitamin d and calcium on tumor response by supplementing it during neoadjuvant chemotherapy in breast cancerTimepoint: at the end of 4 cycles of chemotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the effect of Vitamin D and calcium supplementation during chemotherapy in breast cancer patients on Neutrophil to lymphocytes ratio [NLR] Amelioration of toxic side effects quality of Life.Timepoint: at the end of 4 cycles of chemotherapy | — |
Countries
India
Contacts
Public ContactSukesh KS
King George Medical University UP
Outcome results
None listed